Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Morton

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|April 26, 2007
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|October 5, 2007
Initial testing of dasatinib by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
Pediatric Blood & Cancer|January 29, 2010
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)John M Maris, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Surgery|September 1, 2011
Continuous local delivery of interferon-β stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection modelJason W Denbo, Regan F Williams, W Shannon Orr, et al.
Pediatric Blood & Cancer|December 18, 2009
Initial testing of topotecan by the pediatric preclinical testing programHernan Carol, Peter J Houghton, Christopher L Morton, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|April 26, 2007
Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing programJohn M Maris, Joshua Courtright, Peter J Houghton, et al.
Pediatric Blood & Cancer|October 5, 2007
Initial testing of dasatinib by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Pediatric Blood & Cancer|July 31, 2010
Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing programStephen T Keir, John M Maris, Richard Lock, et al.
Pediatric Blood & Cancer|February 8, 2011
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Richard Lock, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing (stage 1) of vorinostat (SAHA) by the pediatric preclinical testing programNino Keshelava, Peter J Houghton, Christopher L Morton, et al.
Pediatric Blood & Cancer|May 7, 2009
Initial testing of aplidin by the pediatric pre-clinical testing programChristopher L Morton, Peter J Houghton, Richard Gorlick, et al.
Pediatric Blood & Cancer|January 29, 2010
Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)John M Maris, Christopher L Morton, Richard Gorlick, et al.
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Surgery|September 1, 2011
Continuous local delivery of interferon-β stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection modelJason W Denbo, Regan F Williams, W Shannon Orr, et al.
Pediatric Blood & Cancer|December 18, 2009
Initial testing of topotecan by the pediatric preclinical testing programHernan Carol, Peter J Houghton, Christopher L Morton, et al.
Pageof 10